|
|
Volumn 38, Issue 3, 2002, Pages 205-208
|
|
More economical use of cyclosporine through combination drug therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
CALCINEURIN;
CIMETIDINE;
CORTICOSTEROID;
CYCLOPHILIN;
CYCLOSPORIN A;
CYTOCHROME P450;
DILTIAZEM;
DOXYCYCLINE;
ERYTHROMYCIN;
FLAVANOID;
FLUCONAZOLE;
GAMMA INTERFERON;
HISTAMINE;
INTERLEUKIN 2;
INTERLEUKIN 3;
INTERLEUKIN 4;
INTERLEUKIN 5;
ITRACONAZOLE;
KETOCONAZOLE;
LIVER ENZYME;
METHYLPREDNISOLONE;
METOCLOPRAMIDE;
MICROSOME ENZYME;
PHENOBARBITAL;
PREDNISOLONE;
PROSTAGLANDIN;
RIFAMPICIN;
TUMOR NECROSIS FACTOR ALPHA;
UNINDEXED DRUG;
ATOPIC DERMATITIS;
CAT;
CONTROLLED STUDY;
COST CONTROL;
DOG;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG BINDING;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG INDICATION;
DRUG METABOLISM;
DRUG MONITORING;
DRUG POTENTIATION;
ECONOMIC ASPECT;
EDITORIAL;
ENZYME INHIBITION;
FOOD DRUG INTERACTION;
GRAFT REJECTION;
HUMAN;
LIVER TOXICITY;
NONHUMAN;
TRANSCRIPTION REGULATION;
TREATMENT INDICATION;
VETERINARY MEDICINE;
CANIS FAMILIARIS;
FELIS CATUS;
|
|
EID: 0036099409
PISSN: 05872871
EISSN: None
Source Type: Journal
DOI: 10.5326/0380205 Document Type: Editorial |
|
Times cited : (24)
|
|
References (30)
|
